These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21130731)

  • 21. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
    Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
    Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
    Mori M; Uchida M; Watanabe T; Kirito K; Hatake K; Ozawa K; Komatsu N
    J Cell Physiol; 2003 May; 195(2):290-7. PubMed ID: 12652655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukaemia inhibitory factor mediated proliferation of HTR-8/SVneo trophoblast cells is dependent on activation of extracellular signal-regulated kinase 1/2.
    Prakash GJ; Suman P; Morales Prieto DM; Markert UR; Gupta SK
    Reprod Fertil Dev; 2011; 23(5):714-24. PubMed ID: 21635820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
    Ko JC; Tsai MS; Chiu YF; Weng SH; Kuo YH; Lin YW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):184-94. PubMed ID: 21444628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
    Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
    Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Chen KF; Chen HL; Tai WT; Feng WC; Hsu CH; Chen PJ; Cheng AL
    J Pharmacol Exp Ther; 2011 Apr; 337(1):155-61. PubMed ID: 21205925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
    Wang M; Liu ZM; Li XC; Yao YT; Yin ZX
    J Chemother; 2013 Jun; 25(3):162-9. PubMed ID: 23783141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular release of annexin II from pancreatic cancer cells and resistance to anticancer drug-induced apoptosis by supplementation of recombinant annexin II.
    Sato T; Kita K; Sugaya S; Suzuki T; Suzuki N
    Pancreas; 2012 Nov; 41(8):1247-54. PubMed ID: 22750966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.
    Mirmohammadsadegh A; Mota R; Gustrau A; Hassan M; Nambiar S; Marini A; Bojar H; Tannapfel A; Hengge UR
    J Invest Dermatol; 2007 Sep; 127(9):2207-15. PubMed ID: 17508026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment.
    Villedieu M; Deslandes E; Duval M; Héron JF; Gauduchon P; Poulain L
    Gynecol Oncol; 2006 Jun; 101(3):507-19. PubMed ID: 16387351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin.
    Lee MW; Kim DS; Min NY; Kim HT
    Int J Cancer; 2008 May; 122(10):2380-4. PubMed ID: 18224693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
    Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
    Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
    Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
    World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
    Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
    J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2.
    Tang MK; Zhou HY; Yam JW; Wong AS
    Neoplasia; 2010 Feb; 12(2):128-38. PubMed ID: 20126471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activated serine/threonine kinase AKT enhances the radioresistancy in human cholangiocarcinoma].
    Yanagawa N
    Hokkaido Igaku Zasshi; 2003 Mar; 78(2):159-71. PubMed ID: 12704859
    [No Abstract]   [Full Text] [Related]  

  • 40. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma.
    Huo X; Zhang Q; Liu AM; Tang C; Gong Y; Bian J; Luk JM; Xu Z; Chen J
    Oncol Rep; 2013 Feb; 29(2):840-6. PubMed ID: 23232767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.